130 related articles for article (PubMed ID: 14281104)
1. INFLUENCE OF SEROTONIN ANTAGONISTS ON NITROGEN MUSTARD INTOXICATION.
FIELD JB; DOLENDO EC; MIRELES A; ERSHOFF BH
Cancer Res; 1965 Apr; 25():382-6. PubMed ID: 14281104
[No Abstract] [Full Text] [Related]
2. [ATTENUATION OF THE TOXIC EFFECT OF EMBICHIN (HN2) WITH A SEROTONIN ANTAGONIST].
FILD DB; MAIRLES A; DOLENDO ES
Vopr Onkol; 1963; 9():65-8. PubMed ID: 14105961
[No Abstract] [Full Text] [Related]
3. EFFECT OF A SEROTONIN ANTAGONIST ON RADIATION LETHALITY. ANL-6823.
FEINSTEIN RN; SEAHOLM JE
ANL Rep; 1964 Jan; ():99-101. PubMed ID: 14151663
[No Abstract] [Full Text] [Related]
4. [THE ANTI-NITROGEN MUSTARD OF B12 VITAMINS AND COBALT].
BOISSEAU J; PAULET G
Bull Assoc Fr Etud Cancer; 1964; 51():291-9. PubMed ID: 14219568
[No Abstract] [Full Text] [Related]
5. EFFECTS OF ENDOTOXIN AND NITROGEN MUSTARD ON LEUKOCYTE KINETICS.
HERION JC; WALKER RI; HERRING WB; PALMER JG
Blood; 1965 Apr; 25():522-40. PubMed ID: 14284341
[No Abstract] [Full Text] [Related]
6. REVERSAL OF NITROGEN MUSTARD INTOXICATION BY ANTI-HISTAMINES.
FIELD JB; MIRELES A; DOLENDO EC; ERSHOFF BH
Proc Soc Exp Biol Med; 1964 Apr; 115():1060-2. PubMed ID: 14166559
[No Abstract] [Full Text] [Related]
7. TOXICITY OF A NUCLEOTOXIC AGENT, MUSTINE HYDROCHLORIDE, AND ITS ENHANCEMENT BY 5-HYDROXYTRYPTAMINE PRETREATMENT.
UROIC B; RABADJIJA M; SUPEK Z
J Pharm Pharmacol; 1964 Jan; 16():61-2. PubMed ID: 14106568
[No Abstract] [Full Text] [Related]
8. [SOME PHARMACOLOGICAL PROPERTIES OF SEROTONIN ANTAGONISTS DERIVED FROM TRYPTAMINE].
JACOB J; ECHINARD-GARIN P; FELIX M; POITE-BEVIERRE M; MICHAUD G
Therapie; 1963; 18():833-47. PubMed ID: 14072240
[No Abstract] [Full Text] [Related]
9. EFFECT OF A SEROTONIN ANTAGONIST ON RADIATION LETHALITY.
FEINSTEIN RN; SEAHOLM JE
Proc Soc Exp Biol Med; 1963 Oct; 114():247-8. PubMed ID: 14076899
[No Abstract] [Full Text] [Related]
10. SYSTEMIC THIOSULFATE PROTECTION DURING FRACTIONATED REGIONAL NITROGEN MUSTARD THERAPY.
LAWRENCE W; TAYAO MS; MAHAJAN RD; PAGE R; MILLER DG; CLAPP P
J Surg Res; 1964 Nov; 4():483-94. PubMed ID: 14224011
[No Abstract] [Full Text] [Related]
11. [PHARMACOLOGICAL CHARACTERISTICS OF A NEW SEROTONIN ANTAGONIST WITH ANALGESIC AND ANTIPHLOGISTIC PROPERTIES].
CERLETTI A; BERDE B; NEUHOLD K; TAESCHLER M
Boll Chim Farm; 1963 Sep; 102():602-15. PubMed ID: 14091340
[No Abstract] [Full Text] [Related]
12. [STUDIES ON NITROGEN MUSTARD DERIVATIVES, WITH SPECIAL REFERENCE TO THE PHARMACOLOGICAL ACTION OF NITROGEN MUSTARD DERIVATIVES CONTAINING ONLY L BETA-CHLOROETHYL GROUP].
YAMAMOTO I; IWATSUBO K; KIMURA H
Nihon Yakurigaku Zasshi; 1963 Sep; 59():382-90 CONTD. PubMed ID: 14092711
[No Abstract] [Full Text] [Related]
13. CYTOTOXIC ACTIVITY COMPARED WITH PHOTOMETRIC MEASUREMENTS OF SELECTED ALKYLATING AGENTS.
SANDERSON RP; MCKENNA JM; BLAKEMORE WS
Nature; 1965 Jan; 205():479-81. PubMed ID: 14265292
[No Abstract] [Full Text] [Related]
14. URACIL MUSTARD: A POTENT INDUCER OF LUNG TUMORS IN MICE.
ABELL CW; FALK HL; SHIMKIN MB; WEISBURGER EK; WEISBURGER JH; GUBAREFF N
Science; 1965 Mar; 147(3664):1443-5. PubMed ID: 14268720
[TBL] [Abstract][Full Text] [Related]
15. HYPOVOLEMIA FOLLOWING INTRAPERITONEAL NITROGEN MUSTARD THERAPY.
BROWN FE; WRIGHT HK
Surg Gynecol Obstet; 1965 Sep; 121():528-30. PubMed ID: 14332888
[No Abstract] [Full Text] [Related]
16. COMPARATIVE RESPONSE OF A SPECTRUM OF TRANSPLANTABLE RAT NEOPLASMS TO NITROGEN MUSTARD, TRIETHYLENEMELAMINE, AND A GROUP OF BENZALDEHYDE MUSTARD DERIVATIVES.
DUNNING WF; CURTIS MR
Cancer Chemother Rep; 1964 Mar; 36():5-19. PubMed ID: 14152277
[No Abstract] [Full Text] [Related]
17. AUTOLOGOUS MARROW IN TREATMENT OF NITROGEN MUSTARD-INDUCED MARROW DEPRESSION.
KAISER GA; HERTER FP; MARKOWITZ AM; EVANS S
Surgery; 1963 Aug; 54():329-32. PubMed ID: 14054722
[No Abstract] [Full Text] [Related]
18. EFFECT OF PH AND INCUBATION UPON IMMEDIATE LETHAL TOXICITY OF NITROGEN MUSTARD.
WHITE LP; CLAFLIN EF
J Pharmacol Exp Ther; 1964 Mar; 143():285-91. PubMed ID: 14161138
[No Abstract] [Full Text] [Related]
19. [ON AN ATTEMPT AT COMPENSATION OF LEUKOTOXIC SIDE-EFFECTS DURING THE USE OF CYTOSTATICS, BY SUBSTANCES FROM THE TISSUE- OR CELLULAR THERAPY GROUP].
SCHMIDT D
Zentralbl Chir; 1964 Mar; 89():484-9. PubMed ID: 14185467
[No Abstract] [Full Text] [Related]
20. POTENTIAL ANTICANCER AGENTS. II. THE SYNTHESIS OF SOME NITROGEN MUSTARD CONTAINING SULFONES AND THIOSULFINATES.
HIRSCH AF; PIANTADOSI C; IRVIN JL
J Med Chem; 1965 Jan; 8():10-4. PubMed ID: 14287239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
